BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹111 Cr | ₹56 Cr | ₹52 Cr | ₹28 Cr | ₹77 Cr |
What is the latest Sundry Debtors ratio of BALAXI PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹28 Cr |
| Mar2021 | ₹77 Cr |
How is Sundry Debtors of BALAXI PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 98.90 | |
| Mar2024 | ₹56 Cr | 6.55 | |
| Mar2023 | ₹52 Cr | 89.71 | |
| Mar2022 | ₹28 Cr | -64.10 | |
| Mar2021 | ₹77 Cr | - | |
Compare Sundry Debtors of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹145.6 Cr | 10.8% | 41.4% | -61.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹288,761.0 Cr | 6.2% | 13.2% | 1.7% | Stock Analytics | |
| REDINGTON | ₹18,363.9 Cr | 6.3% | 0.2% | 11.5% | Stock Analytics | |
| HONASA CONSUMER | ₹11,244.8 Cr | 0.3% | 28.5% | 58.2% | Stock Analytics | |
| MMTC | ₹10,248.0 Cr | 15.5% | 28.4% | 25.9% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,675.3 Cr | 6.8% | 33% | 45.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 10.8% |
41.4% |
-61.7% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses